Abbott Announces Launch of Next-Generation Embolic Protection System
Emboshield NAV6(TM) Demonstrates Abbott's Continued Leadership in Carotid Therapy ABBOTT PARK, Ill., June 12 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT ) today announced the launch of the sixth-generation Emboshield NAV6(TM) Embolic Protection System for use in carotid artery stenting proc...NEJM study demonstrates carotid stenting with embolic protection is comparable to surgery
WARREN, N.J., April 9, 2008 According to a study published in The New England Journal of Medicine this week, three-year data from the Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy (SAPPHIRE) study in patients with severe blocked carotid arteries, the main bl...Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009
...elf-expanding and balloon-expanding peripheral stents, including the Absolute Pro and Omnilink Elite Peripheral Stent Systems, and the Emboshield Nav6 embolic Protection Device for carotid stenting. ...Avoiding Hysterectomy: Major Interventional Radiology E-collection Info Available
... a randomized study by Gary P. Siskin, M.D., FSIR, and colleagues at Albany Medical College, that answers a key technical question regarding choice of embolic material. Also important are "Economic Evaluation of Uterine Artery Embolization Versus Hysterectomy in the Treatment of Symptomatic Uterine Fibroids:...Abbott Announces EuroPCR 2009 Activities
...ssel closure device with this indication in the European Union. Emboshield Nav6 : Abbott will feature its sixth-generation Emboshield(R) NAV6 embolic Protection System, which is used during carotid stenting procedures to prevent particles of dislodged plaque from flowing to the brain, potentially ca...Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results
... 2008 also included after-tax charges of $2.2 million ($3.3 million pre-tax) for the acceleration of stock awards and discontinuation of the Company's embolic protection platform. In the nine-month period ended March 31, 2009, the total tax-effected impact on earnings per share of equity compensation ...Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
...e, and coronary artery disease. Key products in the vascular pipeline include: the Omnilink Elite(TM) Peripheral Stent System; the EMBOSHIELD NAV6(TM) embolic Protection System for carotid stenting; a fully bioabsorbable drug eluting coronary device; and the XIENCE PRIME(TM) Everolimus Eluting Coronary Stent...New Device Treats Common Heart Rhythm Disorder
...ts are receiving the safest and most effective dose because it can cause serious bleeding if given in doses that are too high, Holmes noted. In the embolic Protection in Patients With Atrial Fibrillation (PROTECT AF) trial, researchers compared treatment with warfarin to a fabric-covered, expandable cage ...Study Shows 80% of Adults with Peripheral Arterial Disease Go Undiagnosed
...will drive sales for PAD treatment devices, particularly for devices such as stents and stent-grafts, and complementary and alternative products, like embolic protection and atherectomy devices." In 2008, the largest segment in the U.S. market for peripheral vascular devices was for stents, which represent...Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
...ckHawk) Plaque Excision System and the SpiderFX(R) embolic Protection Device in the endovascular treatment of...oplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization ...the SilverHawk plaque excision system and SpiderFX embolic protection device, future regulatory submissions a...MGuard(TM) Coronary Stent System Approved in Israel
...vel combination of a coronary stent merged with an embolic protection device. Lifelong embolic protection is achieved by an expandable, flexible ...at wraps the stent. In addition, MGuard(TM) blocks embolic showers and plaque detachment from the arterial wa...Valor Medical Reports Early Clinical Results of New Technology to Treat Cerebral Aneurysms
...iology Conference in New Orleans the early results on the use of a new technology, Neucrylate(TM), to treat cerebral aneurysms. Neucrylate is a liquid embolic that has been developed by Valor Medical, a San Diego, CA, medical device company. "The patients have had very positive results and to date the accumu...Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
...'s NexStent(R) Carotid Stent and FilterWire EZ(TM) embolic Protection System, but also a longer-term benefit ...d Stent when used with the Company's FilterWire EZ embolic Protection System in treating patients at high ris...NT(R) Monorail(R) Endoprosthesis and FilterWire EZ embolic Protection System. CABERNET and BEACH were both pr...SpideRX® Embolic Protection Device
Description: The SpideRX Embolic Protection Device features the ability to use a separate, preferred guidewire to cross the lesion and a pre-loaded nitinol filter with a dual-ended catheter for delivery and recovery. Offering a fully rapid exchange system, the SpideRX Device is easy to use in the indicated appl...Emboshield BareWire Embolic Protection System
Description: With BareWire technology, the wire crosses the lesion first, independent of the filter and delivery catheter. All other actions, including filter placement and retrieval, balloon dilatations, and stent placement then occur over the wire....Emboshield(R) Embolic Protection System
Description: With BareWire technology, the wire crosses the lesion first, independent of the filter and delivery catheter. All other actions, including filter placement and retrieval, balloon dilatations, and stent placement then occur over the wire. Emboshield is designed to capture emboli that can break...RX ACCUNET Embolic Protection System
Description: The RX ACCUNET Embolic Protection System is designed to provide excellent capture capabilities and easy filter control when performing carotid stenting interventions. The ACCUNET is a .014 guide wire based filter system that utilizes rapid exchange technology so that the physician can easily contro...FilterWire EZ Embolic Protection System
Description: Predictable Protection Made Easy. The new generation FilterWire EZ System has focused improvements on effectiveness and ease of use, providing you with the confidence of greater predictability for SVG stenting and angioplasty procedures. The FilterWire EZ System adds predictability to the pro...Proxis Embolic Protection System
Description: Proxis features 'proximal protection' -- providing complete protection from initial crossing to device removal, even in vessels with side branches. Proxis is fast and easy to use. It does not require the attachment or exchange of extra devices for removal of embolic debris. Proxis is...RX ACCULINK Carotid Stent System
Description:...ter compatible for all available stent sizes. The RX ACCULINK utilizes rapid exchange (RX) technology so that a single operator can easily control the embolic protection device and stent delivery system during catheter manipulations....Avoiding hysterectomy: Major interventional radiology E-collection info available
... a randomized study by Gary P. Siskin, M.D., FSIR, and colleagues at Albany Medical College, that answers a key technical question regarding choice of embolic material. Also important are "Economic Evaluation of Uterine Artery Embolization Versus Hysterectomy in the Treatment of Symptomatic Uterine Fibroids:...2 carotid artery stenting studies show results comparable to AHA guidelines
...nts and utilized Abbott's ACCULINK(tm) Carotid Stent System and ACCUNET(tm) embolic Protection System. The EXACT study included 2,124 patients and utilized Abb...id Exchange Carotid Stent System and Emboshield BareWire(tm) Rapid Exchange embolic Protection System. The key objective of both trials was to determine whethe...Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
... stock awards and discontinuation of the Company's embolic protection platform. Including these items, dilut... related to the discontinuation of the Company's embolic protection platform, both of which were incurr...elated to the discontinuation of the Company's embolic protection platform, both of which were incurr...First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
...in a wider range of sizes than any other spherical embolic on the market. They are available in 40, 100, 250,...nt, and precise for the operator. The result is an embolic microsphere that provides accurate and complete ve...r the qualities and characteristics that the ideal embolic device should have. Then, we engineered in those p...ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons
...f treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its pr...ev3 Inc. Appoints John L. Miclot to Board of Directors
...f treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its pr...Valor Medical Closes $1.4 Million Convertible Debt and Receives ISO 13485 Certification
... SAN DIEGO, Nov. 6 /PRNewswire/ -- Valor Medical, Inc., a medical device company that has developed a liquid embolic technology for the treatment of cerebral aneurysms, announced today that they have successfully raised $1.4 million in capital through a convertible d...